Clinical experience with titanium implants, especially with the limited contact dynamic compression plate system

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Medical Device Development

Background:

• Cold-worked pure titanium has demonstrated outstanding biocompatibility for medical implants since the 1960s.
• Pure titanium is the preferred material for patients with metal allergies.
• Extensive clinical experience supports the use of titanium in orthopedic applications.

Purpose of the Study:

• To evaluate the preliminary clinical outcomes of the new titanium limited contact dynamic compression plate (LC-DCP) system.
• To confirm the biocompatibility of pure titanium in the context of the LC-DCP system.

Main Methods:

• Titanium LC-DCPs were implanted in 271 patients for the treatment of fresh fractures starting in 1987.
• Data was collected from pilot clinics on implant usage and removal.
• Preliminary results were analyzed to assess outcomes and biocompatibility.

Main Results:

• A total of 271 titanium LC-DCPs were implanted, primarily for fresh fractures.
• 57 plates were removed, with preliminary results being highly favorable.
• The outstanding biocompatibility of pure titanium was confirmed.

Conclusions:

• The use of pure titanium for the LC-DCP system shows promising preliminary results.
• Pure titanium's biocompatibility is a key advantage for orthopedic implants.
• Titanium LC-DCPs represent a viable option for fracture treatment.